Who is becoming hallucinogen dependent soon after hallucinogen use starts?
Andrea L Stone, Megan S O'Brien, Alejandro De la Torre, James C Anthony
Drug and Alcohol Dependence March 16, 2007 DOI: 10.1016/j.drugalcdep.2006.08.008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 114,241 |
| Population | Non-institutionalized U.S. residents ages 12 and older surveyed in the 2000-2001 National Household Surveys on Drug Abuse, including 2,035 recent-onset hallucinogen users |
| Duration | 24-month follow-up after first hallucinogen use (median elapsed time approximately 12 months) |
| Measures | NHSDA DSM-IV computerized diagnostic algorithm |
| Key findings | An estimated 2-3% of recent-onset hallucinogen users developed hallucinogen dependence within 24 months of first use. Very early first use (ages 10-11) was associated with increased dependence risk, and excess risk was also associated with recent-onset mescaline, ecstasy, and PCP use. The authors characterize the dependence syndrome as tangible but infrequent and call for confirmation in future investigations. |
Abstract
This study, based upon epidemiological survey data from the United States (U.S.) National Household Surveys on Drug Abuse (NHSDA) from 2000 to 2001, presents new estimates for the risk of developing a hallucinogen dependence syndrome within 24 months after first use of any hallucinogen (median elapsed time approximately 12 months). Subgroup variations in risk of becoming hallucinogen dependent also are explored. Estimates are derived from the NHSDA representative samples of non-institutionalized U.S. residents ages 12 and older (n=114,241). A total of 2035 respondents had used hallucinogens for the first time within 24 months prior to assessment. An estimated 2-3% of these recent-onset hallucinogen users had become dependent on hallucinogens, according to the NHSDA DSM-IV computerized diagnostic algorithm. Controlling for sociodemographic and other drug use covariates, very early first use of hallucinogens (age 10-11 years) is associated with increased risk of hallucinogen dependence (p<0.01). Excess risk of developing hallucinogen dependence was found in association with recent-onset use of mescaline; excess risk also was found for recent-onset users of ecstasy and of PCP. This study's evidence is consistent with prior evidence on a tangible but quite infrequent dependence syndrome soon after the start of hallucinogen use; it offers leads that can be confirmed or disconfirmed in future investigations.
Citations in the library
Cited by 13
- Harm potential of magic mushroom use: a review. Regulatory toxicology and pharmacology : RTP April 1, 2011
- Use of psilocybin (“mushrooms”) among US adults: 2015–2018 Journal of Psychedelic Studies February 4, 2021
- Test–re‐test reliability of DSM‐IV adopted criteria for 3,4‐methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross‐national study Addiction August 4, 2009
- Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users International Journal of Drug Policy July 15, 2014
- Salvia divinorum use and phenomenology: results from an online survey. Journal of Psychopharmacology November 1, 2011
and 8 more in the library